In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...